Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)
CNY 6.0
(-0.83%)
CNY 6.0
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.79 Billion | 2.3 Billion | 1.87 Billion | 1.66 Billion | 1.67 Billion | 1.32 Billion |
| Cost of Revenue | 1.04 Billion | 1.41 Billion | 1.04 Billion | 873.6 Million | 873.29 Million | 675.47 Million |
| Gross Profit | 748.4 Million | 888.96 Million | 833.62 Million | 794 Million | 801.86 Million | 646.19 Million |
| Operating Expenses | 564.44 Million | 640.54 Million | 671.24 Million | 567.24 Million | 557.64 Million | 507.07 Million |
| Selling, General and Administrative Expenses | 481.48 Million | 461.79 Million | 507.13 Million | 411.76 Million | 399.37 Million | 358.66 Million |
| Research and Development Expenses | 97.08 Million | 88.31 Million | 71.18 Million | 69.13 Million | 65.37 Million | 67.28 Million |
| Other Expenses | -35.03 Million | 90.43 Million | 92.92 Million | 86.34 Million | 92.88 Million | 1.8 Million |
| Cost and Expenses | 1.6 Billion | 2.05 Billion | 1.71 Billion | 1.44 Billion | 1.43 Billion | 1.18 Billion |
| Operating Income | 204.35 Million | 360 Million | 158.15 Million | 225.63 Million | 300.24 Million | 252.03 Million |
| Interest Expense | 6.16 Million | 5.23 Million | 1.65 Million | 8.44 Million | 18.72 Million | 19.04 Million |
| Income Tax Expense | 24.85 Million | 40.41 Million | 23.03 Million | -21.49 Million | 43.59 Million | 42.79 Million |
| Earnings before Tax | 203.52 Million | 360.33 Million | 209.37 Million | -169.11 Million | 300.5 Million | 253.83 Million |
| Net Income | 181.86 Million | 323.41 Million | 181.07 Million | -147.62 Million | 262.56 Million | 221.34 Million |
| Earnings Per Share Basic | 0.14 | 0.25 | 0.14 | -0.12 | 0.21 | 0.17 |
| Earnings Per Share Diluted | 0.14 | 0.25 | 0.14 | -0.12 | 0.21 | 0.17 |
| Weighted Average Shares Outstanding | 1.29 Billion | 1.27 Billion | 1.24 Billion | 1.24 Billion | 1.25 Billion | 1.26 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.29 Billion | 1.27 Billion | 1.24 Billion | 1.24 Billion | 1.25 Billion | 1.3 Billion |
| Gross Margin | 0.42 | 0.39 | 0.44 | 0.48 | 0.48 | 0.49 |
| EBIT Margin | 0.16 | 0.17 | 0.12 | 0.18 | 0.25 | 0.26 |
| Profit Margin | 0.10 | 0.14 | 0.10 | -0.09 | 0.16 | 0.17 |
| EBITDA | 278.66 Million | 442.64 Million | 281.45 Million | -75.34 Million | 366.49 Million | 336.64 Million |
| Earnings Before Tax Margin | 0.11 | 0.16 | 0.08 | 0.14 | 0.18 | 0.19 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 352 Million | 387.81 Million | 461.1 Million | 1.79 Billion | 343 Million | 409.18 Million |
| Cost of Revenue | 150.57 Million | 196.44 Million | 216.06 Million | 1.06 Billion | 202.07 Million | 221.57 Million |
| Gross Profit | 201.43 Million | 191.37 Million | 245.03 Million | 726.92 Million | 140.92 Million | 187.6 Million |
| Operating Expenses | 146.11 Million | 108.88 Million | 125.55 Million | 574.25 Million | 176.65 Million | 137.37 Million |
| Selling, General and Administrative Expenses | 188.42 Million | 97.93 Million | 104.55 Million | - | 116.07 Million | 157.66 Million |
| Research and Development Expenses | 29.03 Million | 10.99 Million | 17.47 Million | - | 40.96 Million | 12.16 Million |
| Other Expenses | -71.34 Million | 49.65 Thousand | -172.57 Thousand | -6.58 Million | -19.61 Million | 24.36 Million |
| Cost and Expenses | 296.68 Million | 305.33 Million | 341.61 Million | 1.64 Billion | 378.73 Million | 358.94 Million |
| Operating Income | 142.42 Million | 82.48 Million | 117 Million | 152.67 Million | -35.72 Million | 59.65 Million |
| Interest Expense | 190.9 Thousand | 255.35 Thousand | 726.66 Thousand | 5.92 Million | 384.74 Thousand | 1.63 Million |
| Income Tax Expense | 20.08 Million | 13.52 Million | 15.48 Million | 24.85 Million | -6.27 Million | 10.03 Million |
| Earnings before Tax | 142.26 Million | 88.6 Million | 116.83 Million | 203.73 Million | -15.25 Million | 84.01 Million |
| Net Income | 126.79 Million | 78.68 Million | 104.1 Million | 181.86 Million | -15.99 Million | 78.82 Million |
| Earnings Per Share Basic | 0.10 | 0.06 | 0.08 | - | -0.01 | 0.06 |
| Earnings Per Share Diluted | 0.10 | 0.06 | 0.08 | - | -0.01 | 0.06 |
| Weighted Average Shares Outstanding | 1.24 Billion | 1.24 Billion | 1.25 Billion | 1.27 Billion | 1.27 Billion | 1.27 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.24 Billion | 1.24 Billion | 1.25 Billion | 1.27 Billion | 1.27 Billion | 1.27 Billion |
| Gross Margin | 0.57 | 0.49 | 0.53 | 0.41 | 0.41 | 0.46 |
| EBIT Margin | 0.40 | 0.26 | 0.27 | - | -0.05 | 0.19 |
| Profit Margin | 0.36 | 0.20 | 0.23 | 0.10 | -0.05 | 0.19 |
| EBITDA | 142.45 Million | 100.1 Million | 123.19 Million | - | -15.99 Million | 77.34 Million |
| Earnings Before Tax Margin | 0.40 | 0.21 | 0.25 | 0.09 | -0.10 | 0.15 |
GNSMF
002164
001319
ALTR
EMSKF
CHEF